ViVest, founded in 2019, is an innovative medical enterprise focused on the prevention and treatment of ventricular arrhythmias and cardiac rhythm data services.

We are committed to providing comprehensive and innovative solutions for the prevention, monitoring, treatment, and rehabilitation of ventricular arrhythmias globally. In April 2021, we have successfully completed CE (Conformité Européenne) Certification for AED. Our products are already available in multiple countries across Europe, Latin America and Middle East/Africa.

ViVest is the first company in China which independently developed wearable cardioverter defibrillators (WCDs). In the view of the innovation of wearable cardioverter defibrillator and the urgency of clinical needs, evaluated by the Medical Device Technology Evaluation Center of the National Medical Products Administration on January 7, 2021, this product was approved to enter the special review procedure for innovative medical devices, so as to improve the prevention and treatment ability of Sudden Cardiac Death from inside to outside the hospital in China.

ViVest will always adheres to the mission of “Focusing on Technological Innovation, Care for Heart Health”. In the future, we will extend to the development of the world’s first multi-parameter sudden cardiac death risk assessment system through the promotion of wearable products for ventricular arrhythmias and remote data service management. Through the system, ViVest will lead the treatment of sudden cardiac death from passive reaction to the precise treatment of ventricular arrhythmia rhythm management which is a combination of prevention and treatment.